Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedinexSGX:OTX 58 Gross Margin % is 81.43% as of Mar. 2026, which is 9% above its 10-year median of 75.02. GuruFocus rates SGX:OTX with a GF Score™ of 58/100 and a GF Value™ of S$0.20 (Fairly Valued). The stock has 7 warning signs investors should review. Among 627 Healthcare Providers & Services companies, Medinex ranks better than 87.08% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Medinex's Gross Profit for the
six
months ended in Mar. 2026 was S$5.18 Mil. Medinex's Revenue for the
six
months ended in Mar. 2026 was S$6.37 Mil. Therefore, Medinex's Gross Margin % for the quarter that ended in Mar. 2026 was 81.43%.
The historical rank and industry rank for Medinex's Gross Margin % or its related term are showing as below:
SGX:OTX'
s Gross Margin % Range Over the Past 10 Years
Min: 63.28 Med: 75.02 Max: 83.85
Current: 80.2
During the past 10 years, the highestGross Margin % of Medinex was 83.85%. The lowest was 63.28%. And the median was 75.02%.
SGX:OTX's Gross Margin % is ranked better than 87.08% of 627
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs SGX:OTX: 80.20
Medinex had a gross margin of 81.43% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Medinex was 2.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Medinex had a gross margin of 81.43% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Medinex Gross Margin % Related Terms
Medinex Gross Margin % Historical Data
* Premium members only.
The historical data trend for Medinex's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:OTX vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Medinex's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinex Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medinex's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Medinex's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Medinex (SGX:OTX) has a Gross Margin % of 81.43% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Medinex and its competitors. This is near median its historical median of 75.02. Over the past decade, Medinex's Gross Margin % has ranged from 63.28 to 83.85. According to the industry distribution chart, Medinex ranks #81 out of 627 companies in the Healthcare Providers & Services industry, placing it in the top 12.9%.
Is Medinex's Gross Margin % too high?
Medinex's current Gross Margin % of 81.43% is near median its 10-year median of 75.02. Over the past 10 years, this metric has ranged from a low of 63.28 to a high of 83.85. The Healthcare Providers & Services industry median Gross Margin % is 40.06. Medinex's value of 81.43% is 103.3% above this industry median. Based on the distribution chart, Medinex ranks #81 out of 627 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medinex has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medinex's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medinex ranks #81 out of 627 companies for Gross Margin %. This places Medinex in the top 13% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.06. Medinex's value of 81.43% is 103.3% above this benchmark. Historically, Medinex's own Gross Margin % has ranged from 63.28 to 83.85 over the past decade. While the company's 10-year median is 75.02 vs. the industry median of 40.06, Medinex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 627 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinex's current Gross Margin % of 81.43% is 103.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medinex and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinex's current Gross Margin % is 81.43%, which is near median its own 10-year median of 75.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinex stock overvalued right now?
Based on GuruFocus' analysis, Medinex (SGX:OTX) is currently considered Fairly Valued. The stock's GF Value™ is S$0.20, compared to a current price of S$0.22 — trading 10% above its estimated fair value. The current Gross Margin % is 81.43%, which is near median its 10-year median of 75.02 and 103.3% above the Healthcare Providers & Services industry median of 40.06. Medinex's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medinex (SGX:OTX), the current Gross Margin % is 81.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinex (SGX:OTX) Overvalued in 2026?
Based on GuruFocus' analysis, Medinex stock appears to be overvalued.
The current stock price of S$0.22 is trading 10% above its estimated GF Value™ of S$0.20.
GuruFocus considers Medinex to be Fairly Valued.
Key valuation signals for SGX:OTX:
Gross Margin %: 81.43% (near median its 10-year median of 75.02)
GF Value™: S$0.20 vs. price of S$0.22 (10% above fair value)
Industry Position: 103.3% above the Healthcare Providers & Services median (#81 of 627)
No single metric tells the full story. See the SGX:OTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinex Ltd is an investment holding company. The company has four business segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The company generates maximum revenue from the Business Support Services segment. The Business support services business segment provides professional services to customer base who are outside from healthcare industry.
58GF Score
Get the complete analysis for SGX:OTX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:OTX has been successfully added to your 
